GlassScriptPhysician profile
Amber L Morrow
NPI 1902058050
$479.05
in general payments reported to CMS, 2019-2025
10 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.95 · 2023: $84.97 · 2024: $79.39 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $123.83 | 2025 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $122.19 | 2025 | |
| Intuitive Surgical, INC. | $53.95 | 2022 | |
| Janssen Biotech, INC. | $43.11 | 2023-2024 | Stelara |
| Teleflex LLC | $31.69 | 2023-2024 | Titan Sgs Standard Gastric Stapler, Titan Sgs |
| Phathom Pharmaceuticals, INC. | $28.82 | 2024 | Voquezna |
| Abbvie INC. | $22.61 | 2024 | |
| Kerecis Limited | $21.87 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.26 | 2023 | Trulance |
| Conmed Corporation | $14.72 | 2025 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Morrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.